GLP-1 Receptor Agonist and Stroke Prevention in Patients With and Without Diabetes

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

GLP-1 Receptor Agonist and Stroke Prevention in Patients With and Without Diabetes

By Cleveland Clinic Neurological Institute FEATURING Wei Zhang

533 views

August 21, 2024

0 Comments

A Journey Through Clinical Efficacy and Safety Data Comparing Two T2…

Feat. B. Hirsch

Initiating and Monitoring Patients on a Non-Statin Lipid-Lowering Th…

Feat. R. Sugumaran, P. Shah, S. Shugg

Future of Stroke Care: Stroke and Cerebrovascular Disease Conference

Sat, Nov 9, 2024

SVIN Mission Thrombectomy

SVIN 2024 Annual Meeting

Wed, Nov 20, 2024

64:45

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi

26:11

13th Orange County Symposium for Cardiovascular Disease Prevention

Update on Calcium Screening and CTA: Role in Prevention

Feat. M. Budoff

49:21

Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key

26:57

Houston Methodist

Endoscopic Weight Loss Therapies - A Paradigm Shift in the Treatment…

Feat. T. R. Mccarty

21:34

Canadian Collaborative Research Network

Should Colchicine Become Standard Therapy for CAD?

Feat. P. Ridker

18:43

ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo

20:15

Omnipod®

Type 2 Diabetes and Omnipod® 5--Unveiling SECURE T2D

Feat. F. Pasquel

15:06

Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

12:26

Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

27:24

Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan

15:33

Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

16:08

Omnipod®

Unlock the Future of Type 2 Diabetes Care (featuring Dr. Viral Shah)

Feat. V. Shah

21:33

AdventHealth

FLOW: The First Dedicated CKD Outcomes Trial With a GLP-1 Receptor A…

Feat. R. Pratley

26:49

Diana Isaacs

Tirzepatide Updates

08:35

Susan Brian

Labs to Check on Semaglutide or Tirzepatide

20:24

Diana Isaacs

Tirzepatide for Type 2 Diabetes

07:41

Susan Brian

Weightloss in Menopause

07:22

Canadian Collaborative Research Network

TACT2 – Does Chelation Reduce Events in Diabetic Post-MI Patients?

Feat. N. Singh

06:31

Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

05:08

Susan Brian

Login

Login

Join VuMedi

GLP-1 Receptor Agonist and Stroke Prevention in Patients With and Without Diabetes

Related Content